Literature DB >> 14628969

National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness.

Marilyn D Farber1.   

Abstract

OBJECTIVE: To describe the population registered as blind in Israel and estimate the prevalence and incidence of blindness, by age, sex and the causes of blindness.
METHODS: Israel has maintained a Registry for the Blind since 1987. Patients are identified by ophthalmologists and registered if they have a visual acuity of < or = 0.05 (20/400) or a visual field of < 20 degrees radius in their better eye. The Registry consists of all eligible citizens living in Israel at the time of registration. This report includes prevalence data on 18,891 persons enrolled in the Registry from 1987-1999 and still alive and living in Israel in 1999, and incidence data on 2,511 persons newly registered in 1999. Data were collected on visual acuity and visual field loss, cause of blindness, and patient demographics.
RESULTS: In 1999, the estimated prevalence rate of blindness nationwide was 0.31% and the estimated incidence rate was 0.037%. The major causes of blindness in the complete Registry were age related macular degeneration (AMD) and glaucoma (14%), followed by diabetic retinopathy (11%), cataract and myopic maculopathy (10%), and optic atrophy (8.4%). The leading causes of newly diagnosed blindness were age-related macular degeneration (AMD) (20%), glaucoma (14%), diabetic retinopathy (12%), myopic maculopathy (11%), and optic atrophy and cataract (10%).
CONCLUSIONS: Israel has one of the few nationwide blindness registries in the world. The prevalence and incidence of blindness in Israel appear to be comparable to other western countries. Comparisons are difficult because of different definitions of blindness, age distributions, and the uniqueness of the Israeli Registry.

Entities:  

Mesh:

Year:  2003        PMID: 14628969     DOI: 10.1076/opep.10.4.267.15910

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  7 in total

1.  [Epidemiology of severe visual impairment and blindness of old people in Germany].

Authors:  M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

2.  Childhood visual impairment and blindness: 5-year data from a tertiary low vision center in Israel.

Authors:  Claudia Yahalom; Ron Braun; Rani Patal; Ibrahim Saadeh; Anat Blumenfeld; Michal Macarov; Karen Hendler
Journal:  Eye (Lond)       Date:  2021-08-23       Impact factor: 4.456

Review 3.  Global Prevalence and Causes of Visual Impairment and Blindness in Children: A Systematic Review and Meta-Analysis.

Authors:  Abbasali Yekta; Elham Hooshmand; Mohammad Saatchi; Hadi Ostadimoghaddam; Amir Asharlous; Azadeh Taheri; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2022-04-16

4.  Trends in blind registration in the adult population of the Republic of Ireland 1996-2003.

Authors:  C Kelliher; D Kenny; C O'Brien
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

5.  Blindness and visual impairment in Germany: a slight fall in prevalence.

Authors:  Robert P Finger; Bernd Bertram; Christian Wolfram; Frank G Holz
Journal:  Dtsch Arztebl Int       Date:  2012-07-09       Impact factor: 5.594

6.  Visual Impairment Registry of Patients from North Kolkata, Eastern India: A Hospital-based Study.

Authors:  Sabyasachi Bandyopadhyay; Samir Kumar Bandyopadhyay; Jaya Biswas; Mita Saha Dutta Chowdhury; Asim Kumar Dey; Asim Chakrabarti
Journal:  J Ophthalmic Vis Res       Date:  2018 Jan-Mar

7.  Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling.

Authors:  Timothy R Fricke; Monica Jong; Kovin S Naidoo; Padmaja Sankaridurg; Thomas J Naduvilath; Suit May Ho; Tien Yin Wong; Serge Resnikoff
Journal:  Br J Ophthalmol       Date:  2018-04-26       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.